Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 5
2000 3
2001 3
2002 3
2003 1
2004 2
2005 4
2006 2
2007 4
2008 4
2009 2
2010 4
2011 7
2012 3
2013 7
2014 3
2015 4
2016 7
2017 7
2018 3
2019 4
2020 13
2021 7
2022 7
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Results by year
Filters applied: . Clear all
Page 1
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J; IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Conference Participants. Trimarchi H, et al. Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22. Kidney Int. 2017. PMID: 28341274 Free article. Review.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Among authors: trimarchi h. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
[Myelomatous ascites].
Young P, Finn BB, Pellegrini D, Bruetman JE, Shanley CM, Tolosa Vilell C, Trimarchi H. Young P, et al. Among authors: trimarchi h. An Med Interna. 2008 Feb;25(2):85-9. doi: 10.4321/s0212-71992008000200008. An Med Interna. 2008. PMID: 18432366 Review. Spanish.
Hyponatremia-associated rhabdomyolysis.
Trimarchi H, Gonzalez J, Olivero J. Trimarchi H, et al. Nephron. 1999;82(3):274-7. doi: 10.1159/000045413. Nephron. 1999. PMID: 10396001 Review.
Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome.
Trimarchi H, Gianserra R, Lampo M, Monkowski M, Lodolo J. Trimarchi H, et al. Clin Kidney J. 2020 Sep 27;13(5):739-741. doi: 10.1093/ckj/sfaa166. eCollection 2020 Oct. Clin Kidney J. 2020. PMID: 33117528 Free PMC article.
Crescents and IgA Nephropathy: A Delicate Marriage.
Trimarchi H, Haas M, Coppo R. Trimarchi H, et al. J Clin Med. 2022 Jun 21;11(13):3569. doi: 10.3390/jcm11133569. J Clin Med. 2022. PMID: 35806856 Free PMC article. Review.
Podocyturia: What is in a name?
Trimarchi H. Trimarchi H. J Transl Int Med. 2015 Apr-Jun;3(2):51-56. doi: 10.1515/jtim-2015-0003. Epub 2015 Jun 30. J Transl Int Med. 2015. PMID: 27847887 Free PMC article. Review.
Why Target the Gut to Treat IgA Nephropathy?
Barratt J, Rovin BH, Cattran D, Floege J, Lafayette R, Tesar V, Trimarchi H, Zhang H; NefIgArd Study Steering Committee. Barratt J, et al. Among authors: trimarchi h. Kidney Int Rep. 2020 Aug 20;5(10):1620-1624. doi: 10.1016/j.ekir.2020.08.009. eCollection 2020 Oct. Kidney Int Rep. 2020. PMID: 33102954 Free PMC article. No abstract available.
Biomarkers in acute kidney injury: Evidence or paradigm?
Lombi F, Muryan A, Canzonieri R, Trimarchi H. Lombi F, et al. Among authors: trimarchi h. Nefrologia. 2016 Jul-Aug;36(4):339-46. doi: 10.1016/j.nefro.2016.01.012. Epub 2016 May 17. Nefrologia. 2016. PMID: 27207821 Free article. Review. English, Spanish.
98 results